4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-19-015713
President and General Counsel sold 32,336 shares at an average $20.35 ($657,930)
- President and General Counsel gave up 23,512 shares (to pay taxes)
- President and General Counsel acquired 24,508 shares (option exercise)
- President and General Counsel acquired 39,050 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shandell Jason B. President and General Counsel | 2019-03-14 | Sale | −7,828 | $20.37 | $159,489 | 160,490 | D |
| Shandell Jason B. President and General Counsel | 2019-03-15 | Option exercise | +24,508 | $10.93 | $267,872 | 184,998 | D |
| Shandell Jason B. President and General Counsel | 2019-03-15 | Sale | −24,508 | $20.34 | $498,441 | 160,490 | D |
| Shandell Jason B. President and General Counsel | 2019-03-15 | Grant or award | +39,050 | 199,540 | D | ||
| Shandell Jason B. President and General Counsel | 2019-03-15 | Shares withheld for taxes | −5,255 | $20.23 | $106,309 | 194,285 | D |
| Shandell Jason B. President and General Counsel | 2019-03-16 | Shares withheld for taxes | −8,381 | $20.23 | $169,548 | 185,904 | D |
| Shandell Jason B. President and General Counsel | 2019-03-17 | Shares withheld for taxes | −9,876 | $20.23 | $199,791 | 176,028 | D |
| Derivatives | |||||||
| Shandell Jason B. President and General Counsel | 2019-03-15 | Option exercise · Employee Stock Option (right to buy) | −24,508 | 44,149 | D | ||
| Shandell Jason B. President and General Counsel | 2019-03-15 | Grant or award · Employee Stock Option (right to buy) | +86,862 | 86,862 | D | ||
| Open-market sales · 32,336 sh · avg $20.35 · $657,930 | |||||||
Loading xslF345X03/a4.xml…